Literature DB >> 10982390

A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

J S Park1, L Qiao, D Gilfor, M Y Yang, P B Hylemon, C Benz, G Darlington, G Firestone, P B Fisher, P Dent.   

Abstract

In primary hepatocytes and HepG2 hepatoma cells, prolonged activation of the p42/44 mitogen-activated protein kinase (MAPK) pathway is associated with a reduction in DNA synthesis, mediated by increased expression of the cyclin-dependent kinase inhibitor protein p21 (Cip-1/WAF1/mda6) (p21). This study was performed to evaluate the contribution of transcriptional and post-transcriptional regulation in this response. Prolonged activation of the MAPK pathway in wild-type or p21 null hepatocytes caused a large decrease and increase, respectively, in DNA synthesis. Prolonged activation of the MAPK pathway in either wild-type or p21 antisense HepG2 cells also caused large decreases and increases, respectively, in DNA synthesis. MAPK signaling increased the phosphorylation of the transcription factors Ets2, C/EBPalpha, and C/EBPbeta, and rapidly increased transcription from the p21 promoter via multiple Ets- and C/EBP-elements within the enhancer region. Eight hours after MAPK activation, loss of C/EBPbeta or Ets2 function significantly reduced MAPK-stimulated transcription from the p21 promoter and abolished increased p21 protein expression. At this time, MAPK signaling increased both p21 mRNA and p21 protein stabilities that were also demonstrated to be essential for a profound increase in p21 protein levels. Thirty-six hours after MAPK activation, transcription from the p21 promoter was still significantly reduced in cells without either C/EBPbeta or Ets2 function; however, these cells were now capable of exhibiting a partial increase in p21 protein expression. In contrast, loss of C/EBPalpha function modestly reduced MAPK-stimulated transcription from the p21 promoter but strongly inhibited the ability of prolonged MAPK activation to increase protein levels of p21. This data suggested that prolonged enhancement of p21 protein levels may be under posttranscriptional control. In agreement with this hypothesis, prolonged MAPK signaling further increased p21 mRNA stability at 36 h, compared with the 8-h time point. Our data argue that MAPK signaling increased p21 promoter activity via multiple transcription factors, which alone were insufficient for a robust prolonged increase in p21 protein levels in primary hepatocytes, and that to increase p21 protein levels also required enhanced stabilization of p21 mRNA and p21 protein. Collectively, these data suggest that loss of transcription factor and mRNA/protein stabilization functions correlates with an inability of MAPK signaling to cause growth arrest versus proliferation in primary hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982390      PMCID: PMC14965          DOI: 10.1091/mbc.11.9.2915

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  56 in total

1.  Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration.

Authors:  J H Albrecht; A H Meyer; M Y Hu
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

Review 2.  Liver regeneration.

Authors:  G K Michalopoulos; M C DeFrances
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

3.  p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication.

Authors:  M S Serfas; E Goufman; M H Feuerman; A L Gartel; A L Tyner
Journal:  Cell Growth Differ       Date:  1997-09

4.  Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes.

Authors:  M S Spector; K L Auer; W D Jarvis; E J Ishac; B Gao; G Kunos; P Dent
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1.

Authors:  P Loyer; S Cariou; D Glaise; M Bilodeau; G Baffet; C Guguen-Guillouzo
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

6.  Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells.

Authors:  J S Park; S Carter; D B Reardon; R Schmidt-Ullrich; P Dent; P B Fisher
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

7.  CCAAT/enhancer-binding protein delta gene expression is mediated by APRF/STAT3.

Authors:  T Yamada; K Tobita; S Osada; T Nishihara; M Imagawa
Journal:  J Biochem       Date:  1997-04       Impact factor: 3.387

8.  Differential regulation of hepatocyte DNA synthesis by cAMP in vitro in vivo.

Authors:  J K Westwick; J Fleckenstein; M Yin; S Q Yang; C A Bradham; D A Brenner; A M Diehl
Journal:  Am J Physiol       Date:  1996-11

9.  CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein.

Authors:  N A Timchenko; M Wilde; M Nakanishi; J R Smith; G J Darlington
Journal:  Genes Dev       Date:  1996-04-01       Impact factor: 11.361

10.  Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.

Authors:  Y Imai; H Oda; M Arai; S Shimizu; Y Nakatsuru; T Inoue; T Ishikawa
Journal:  Jpn J Cancer Res       Date:  1996-10
View more
  31 in total

1.  Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice.

Authors:  Andrew I Su; Luca G Guidotti; John Paul Pezacki; Francis V Chisari; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

2.  Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Authors:  Drew Burdon; Rajnikant Patel; R A John Challiss; Jonathan L Blank
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

3.  High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.

Authors:  Adrian Box; Mohammed Alshalalfa; Samar A Hegazy; Bryan Donnelly; Tarek A Bismar
Journal:  Tumour Biol       Date:  2016-06-07

4.  Control of adipogenesis by the SUMO-specific protease SENP2.

Authors:  Sung Soo Chung; Byung Yong Ahn; Min Kim; Hye Hun Choi; Ho Seon Park; Shinae Kang; Sang Gyu Park; Young-Bum Kim; Young Min Cho; Hong Kyu Lee; Chin Ha Chung; Kyong Soo Park
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

5.  Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.

Authors:  Margaret A Park; Roland Reinehr; Dieter Häussinger; Christina Voelkel-Johnson; Besim Ogretmen; Adly Yacoub; Steven Grant; Paul Dent
Journal:  Mol Cancer Ther       Date:  2010-08-03       Impact factor: 6.261

6.  Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.

Authors:  Jinghua Bie; Bin Zhao; Kathryn E Marqueen; Jing Wang; Barbara Szomju; Shobha Ghosh
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-06       Impact factor: 4.310

7.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

8.  PDEF is a negative regulator of colon cancer cell growth and migration.

Authors:  Omar Moussa; David P Turner; Ron J Feldman; Victor I Sementchenko; Brent D McCarragher; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

9.  Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.

Authors:  Shyam N Sundar; Crystal N Marconett; Victor B Doan; Jamin A Willoughby; Gary L Firestone
Journal:  Carcinogenesis       Date:  2008-09-10       Impact factor: 4.944

10.  Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells.

Authors:  George P Amorino; Virginia M Hamilton; Kristoffer Valerie; Paul Dent; Guido Lammering; Rupert K Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.